HOME Top Market Reports Mycoplasma Testing Market by Products (Instruments, Kits & Reagents, Services), Application (Cell Line, Virus, End of Production Cells), Technology (PCR, ELISA, Direct Assay), End User (Cell Banks, Pharmaceutical Companies) - Global Forecast to 2019

Mycoplasma Testing Market by Products (Instruments, Kits & Reagents, Services), Application (Cell Line, Virus, End of Production Cells), Technology (PCR, ELISA, Direct Assay), End User (Cell Banks, Pharmaceutical Companies) - Global Forecast to 2019

By: marketsandmarkets.com
Publishing Date: April 2015
Report Code: BT 3371

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global mycoplasma testing market is expected to reach $613.49 Million by 2019 from $340.29 Million in 2014, growing at a CAGR of 12.51% between 2014 and 2019. Mycoplasma contamination of cell lines and bio therapeutic products represents a significant biosafety concern. The ubiquitous nature of mycoplasma in the environment increases the likelihood of the introduction of these organisms into manufacturing processes. A variety of mycoplasma detection protocols are used in research. Testing is carried out to ensure product quality and safety during different stages of manufacturing process. Mycoplasma testing market refers to a wide range of assays and services aimed at ensuring the quality and purity of products and raw materials used in the production of biologics for the pharmaceutical and biotech industries.

The major drivers for the market include rapid growth in pharmaceutical and biotechnology companies, strong trend of R&D investments in life sciences, increasing government support for pharmaceutical and biotechnology industries and increasing number of new drug launches. However, consolidated market acts as a restraint for new entrants in the market.

Emerging economies are making huge investments in R&D as opportunities in biopharmaceuticals are big and growing very rapidly. The biopharmaceuticals generate global revenues of $163 Billion, contributing to about 20% of the pharmaceutical market. It is the fastest growing area of the industry. Biopharmaceutical’s current annual growth rate is more than 8% and is double that of conventional pharma, and is expected to grow more in foreseeable future. This high growth rate, will act as an important driver of the mycoplasma testing market. Also, increase in new drug launches and R&D investments will aid to the growth of this market.

In this report, the global mycoplasma testing market is segmented based on product, technology, application, end user and geography. Based on products the market is segmented into kits & reagents, instruments and services. Based on technology, the market is segmented into direct assay, indirect assay, DNA staining, microbial culture techniques, PCR, enzymatic methods and ELISA. Based on applications the market is segmented into cell line testing, virus testing, end of production cells testing and other applications. The end users for this market include contract research organizations, academic research institutes, pharmaceutical and biotechnology companies, cell banks, and other end users. Based on geography the global market is segmented into North America, Europe, Asia and Rest of the World (RoW).

The top leaders in mycoplasma testing market include Merck KGaA (Germany), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), Lonza Group Ltd. (Switzerland), Charles River Laboratories International, Inc. (U.S.), Promo Cell GmbH (Germany), Bionique Testing Laboratories, Inc. (U.S.), American Type Culture Collection (U.S.), InvivoGen.(U.S.), Biological Industries Israel Beit Haemek Ltd. (Israel) and others.

Scope of the Report

This research report categorizes the global mycoplasma testing market into the following segments and sub segments:

Global Mycoplasma Testing Market, by Type of Product

  • Instruments
  • Kits & Reagents
    • PCR Assays
    • Nucleic Acid Detection Kits
    • Stains
    • Elimination Kits
    • Standards & Controls
    • Others
  • Services

Global Mycoplasma Testing Market, by Technology

  • PCR
  • ELISA
  • Direct Assay
  • Indirect Assay
  • Microbial Culture Techniques
  • Enzymatic Methods

Global Mycoplasma Testing Market, by Application

  • Cell Line Testing
  • Virus Testing
  • End of Production Cells Testing
  • Other Applications

Global Mycoplasma Testing Market, by End User

  • Academic Research Institutes
  • Cell Banks
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

Global Mycoplasma Testing Market, by Geography

  • Asia
  • Europe
  • North America
  • Rest of the World

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Assumptions

3 Executive Summary (Page No. - 26)

4 Premium Insights (Page No. - 32)
    4.1 Mycoplasma Testing Market to Grow at A High Rate
    4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. - 36)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 Mycoplasma Testing Market, By Product
           5.2.2 Mycoplasma Testing Market, By Technology
           5.2.3 Mycoplasma Testing Market, By Application
           5.2.4 Mycoplasma Testing Market, By Enduser
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Rapid Growth in Pharmaceutical and Biotechnology Industries
                    5.3.1.2 Strong Trend of R&D Investments in Life Sciences
                    5.3.1.3 Increasing Government Support for Pharmaceutical and Biotechnology Industries
           5.3.2 Restraints
                    5.3.2.1 High Degree of Consolidation Acts as an Entry Barrier for New Entrants
                    5.3.2.2 Stringent Regulatory Frameworks and Time-Consuming Approval Processes
           5.3.3 Opportunities
                    5.3.3.1 Increasing Pharmaceutical Outsourcing

6 Industry Insights (Page No. - 45)
    6.1 Introduction
    6.2 Porter’s Five Forces Analysis
           6.2.1 Threat From New Entrants
           6.2.2 Threat From Substitutes
           6.2.3 Bargaining Power of Buyers
           6.2.4 Bargaining Power of Suppliers
           6.2.5 Competitive Rivalry Among Existing Players
    6.3 Strategic Benchmarking
           6.3.1 Agreements, Collaborations, and Partnerships
    6.4 Supply Chain Analysis
           6.4.1 Key Influencers

7 Mycoplasma Testing Market, By Product (Page No. - 50)
    7.1 Introduction
    7.2 KITS & Reagents
           7.2.1 PCR Assays
           7.2.2 Nucleic Acid Detection KITS
           7.2.3 Elimination KITS& Reagents
           7.2.4 Stains
           7.2.5 Standards & Controls
           7.2.6 Others KITS & Reagents
    7.3 Instruments
    7.4 Services

8 Mycoplasma Testing Market, By Technology (Page No. - 64)
    8.1 Introduction
    8.2 PCR
    8.3 Elisa
    8.4 Direct Assay
    8.5 Indirect Assay
    8.6 Dna Staining
    8.7 Microbial Culture Techniques
    8.8 Enzymatic Methods

9 Mycoplasma Testing Market, By Application (Page No. - 74)
    9.1 Introduction
    9.2 Cell Line Testing
    9.3 Virus Testing
    9.4 End of Production Cells Testing
    9.5 Other Applications

10 Mycoplasma Testing Market, By End User (Page No. - 82)
     10.1 Introduction
     10.2 Pharmaceutical and Biotechnology Companies
     10.3 Contract Research Organizations
     10.4 Academic Research Institutes
     10.5 Cell Banks
     10.6 Other End Users

11 Geographic Analysis (Page No. - 93)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
     11.4 Asia
     11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. - 133)
     12.1 Introduction
     12.2 Market Share Analysis, Mycoplasma Testing Market
     12.3 Competitive Situation and Trends
             12.3.1 Agreements, Collaborations and Partnerships
             12.3.2 Expansion
             12.3.3 Acquisitions
             12.3.4 New Product and Service Launches
             12.3.5 Other Strategies

13 Company Profiles (Page No. - 144)
     13.1 Introduction
     13.2 Charles River Laboratories International, Inc.
             13.2.1 Business Overview
             13.2.2 Products & Services
             13.2.3 Recent Developments
             13.2.4 MNM View
                        13.2.4.1 Financial Analysis
                        13.2.4.2 Strategic Analysis
     13.3 Lonza Group Ltd.
             13.3.1 Business Overview
             13.3.2 Products & Services
             13.3.3 Recent Developments
             13.3.4 MNM View
                        13.3.4.1 Financial Analysis
                        13.3.4.2 Strategic Analysis
     13.4 Merck KGaA (Germany).
             13.4.1 Business Overview
             13.4.2 Product Portfolio
             13.4.3 Recent Developments
             13.4.4 MNM View
                        13.4.4.1 Financial Analysis
                        13.4.4.2 Strategic Analysis
     13.5 Sigma-Aldrich Corporation
             13.5.1 Business Overview
             13.5.2 Product Portfolio
             13.5.3 Recent Developments
             13.5.4 MNM View
                        13.5.4.1 Financial Analysis
                        13.5.4.2 Strategic Analysis
     13.6 Thermo Fisher Scientific, Inc.
             13.6.1 Business Overview
             13.6.2 Product Portfolio
             13.6.3 Recent Developments
             13.6.4 MNM View
                        13.6.4.1 Financial Analysis
                        13.6.4.2 Strategic Analysis
     13.7 American Type Culture Collection
             13.7.1 Business Overview
             13.7.2 Products & Services
             13.7.3 Recent Developments
             13.7.4 Key Strategy
     13.8 Biological Industries Israel Beit Haemek Ltd.
             13.8.1 Business Overview
             13.8.2 Product Portfolio
             13.8.3 Key Strategy
     13.9 Bionique Testing Laboratories, Inc.
             13.9.1 Business Overview
             13.9.2 Products & Services
             13.9.3 Key Strategy
     13.10 Invivogen
             13.10.1 Business Overview
             13.10.2 Product Portfolio
             13.10.3 Key Strategy
     13.11 Promo Cell GMBH
             13.11.1 Product Portfolio
             13.11.2 Key Strategy

14 Appendix (Page No. - 170)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Introducing RT: Real Time Market Intelligence
     14.4 Available Customizations
     14.5 Related Reports


List of Tables (74 Tables)

Table 1 Mycoplasma Testing Market Summary
Table 2 Rapid Growth in the Pharmaceutical and Biotechnology Industries is Propelling the Growth of Mycoplasma Testing Market
Table 3 High Degree of Consolidation Acts as an Entry Barrier for New Entrants
Table 4 Increasing Pharmaceutical Outsourcing are Paving New Growth Avenues for Players in the Mycoplasma Testing Market
Table 5 Market Developments Between 2011 and 2015
Table 6 Market Size, By Product, 2012–2019 ($Million)
Table 7 Mycoplasma Testing KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 8 Mycoplasma Testing KITS & Reagents Market Size, By Region, 2012–2019 ($Million)
Table 9 PCR Assay Market Size, By Region, 2012–2019 ($Million)
Table 10 Nucleic Acid Detection KITS Market Size, By Region, 2012–2019 ($Million)
Table 11 North America Commanded the Largest Share of Eliminations KITS & Reagents Segment in 2014
Table 12 Eliminations KITS & Reagents Market Size, By Region, 2012–2019 ($Million)
Table 13 Mycoplasma Testing Stains Market Size, By Region, 2012–2019 ($Million)
Table 14 Standards & Controls Market Size, By Region, 2012–2019 ($Million)
Table 15 Other KITS & Reagents Market Size, By Region, 2012–2019 ($Million)
Table 16 Mycoplasma Testing Instruments Market Size, By Region, 2012–2019 ($Million)
Table 17 Mycoplasma Testing Services Market Size, By Region, 2012–2019 ($Million)
Table 18 Mycoplasma Testing Market Size, By Technology, 2012–2019 ($Million)
Table 19 PCR Method Market Size, By Region, 2012–2019 ($Million)
Table 20 Elisa Method Market Size, By Region, 2012–2019 ($Million)
Table 21 Direct Assay Market Size, By Region, 2012–2019 ($Million)
Table 22 Indirect Assay Market Size, By Region, 2012–2019 ($Million)
Table 23 North America Dominated the Largest Share of the DNA Staining Technology Segment in 2014
Table 24 DNA Staining Market Size, By Region, 2012–2019 ($Million)
Table 25 Microbial Culture Techniques Market Size, By Region, 2012–2019 ($Million)
Table 26 Enzymatic Methods Market Size, By Region, 2012–2019 ($Million)
Table 27 Mycoplasma Testing Market Size, By Application, 2012–2019 ($Million)
Table 28  Market Size for Cell Line Testing, By Region, 2012–2019 ($Million)
Table 29 Market Size for Virus Testing, By Region, 2012–2019 ($Million)
Table 30 Market Size for End of Production Cells Testing Applications, By Region, 2012–2019 ($Million)
Table 31 Mycoplasma Testing Market Size for Other Applications, By Region, 2012–2019 ($Million)
Table 32  Market Size, By End User, 2012–2019 ($Million)
Table 33 Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2012–2019 ($Million)
Table 34 Mycoplasma Testing Market Size for Contract Research Organizations, By Region, 2012–2019 ($Million)
Table 35 Market Size for Academic Research Institutes, By Region, 2012–2019 ($Million)
Table 36 Market Size for Cell Banks, By Region, 2012–2019 ($Million)
Table 37 Market Size for Other End Users, By Region, 2012–2019 ($Million)
Table 38 Market Size, By Region, 2012–2019 ($Million)
Table 39 North America: Mycoplasma Testing Market Size, By Country, 2012–2019 ($Million)
Table 40 North America:  Market Size, By Product, 2012–2019 ($Million)
Table 41 North America: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 42 North America:  Market Size, By Technology, 2012–2019 ($Million)
Table 43 North America: Market Size, By Application, 2012–2019 ($Million)
Table 44 North America: Market Size, By End User, 2012–2019 ($Million)
Table 45 U.S.: Mycoplasma Testing Market Size, By Product, 2012–2019 ($Million)
Table 46 U.S.: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 47 U.S.: Market Size, By Technology, 2012–2019 ($Million)
Table 48 U.S.:  Market Size, By Application, 2012–2019 ($Million)
Table 49 U.S.:  Market Size, By End User, 2012–2019 ($Million)
Table 50 Canada: Mycoplasma Testing Market Size, By Product, 2012–2019 ($Million)
Table 51 Canada: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 52 Canada: Market Size, By Technology, 2012–2019 ($Million)
Table 53 Canada: Market Size, By Application, 2012–2019 ($Million)
Table 54 Canada: Market Size, By End User, 2012–2019 ($Million)
Table 55 Europe: Mycoplasma Testing Market Size, By Product, 2012–2019 ($Million)
Table 56 Europe: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 57 Europe: Market Size, By Technology, 2012–2019 ($Million)
Table 58 Europe:  Market Size, By Application, 2012–2019 ($Million)
Table 59 Europe:  Market Size, By End User, 2012–2019 ($Million)
Table 60 Asia: Mycoplasma Testing Market Size, By Product, 2012–2019 ($Million)
Table 61 Asia: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 62 Asia: Market Size, By Technology, 2012–2019 ($Million)
Table 63 Asia:  Market Size, By Application, 2012–2019 ($Million)
Table 64 Asia: Market Size, By End User, 2012–2019 ($Million)
Table 65 RoW: Mycoplasma Testing Market Size, By Product, 2012–2019 ($Million)
Table 66 RoW: KITS & Reagents Market Size, By Type, 2012–2019 ($Million)
Table 67 RoW:  Market Size, By Technology, 2012–2019 ($Million)
Table 68 RoW: Market Size, By Application, 2012–2019 ($Million)
Table 69 RoW:  Market Size, By End User, 2012–2019 ($Million)
Table 70 Agreements, Collaborations and Partnerships, 2011–2015
Table 71 Expansions, 2011–2015
Table 72 Acquisitions, 2011–2015
Table 73 New Product & Service Launches, 2011–2015
Table 74 Other Development, 2011–2015
 
 
List of Figures (103 Figures)
 
Figure 1 Global Mycoplasma Testing Market
Figure 2 Research Methodology
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Mycoplasma Testing Market Size, By Product, 2014 ($Million)
Figure 8 Market Size, KITS & Reagents By Type, 2014 ($Million)
Figure 9  Market Size, By Technology, 2014 ($Million)
Figure 10 Market Size, By Application, 2014 ($Million)
Figure 11 Market Size, By End User, 2014 ($Million)
Figure 12 Market Size, By Geography, 2014 ($Million)
Figure 13 Increasing Research and Development Activities and Pharmaceutical Outsourcing are Important Growth Drivers
Figure 14 KITS & Reagents to Dominate the Mycoplasma Testing Market
Figure 15 Asia to Grow at the Highest Rate During the Forecast Period
Figure 16 Asian Market Showcases Lucrative Growth Opportunities
Figure 17 Market Segmentation: By Product
Figure 18 Market Segmentation: By Technology
Figure 19 Market Segmentation: By Application
Figure 20 Market Segmentation: By End User
Figure 21 Growth in Pharmaceutical and Biotechnology Industries Will Drive the Mycoplasma Testing Market
Figure 22 Increasing R&D Investments is an Important Driver for this Market
Figure 23 Porter’s Five Forces Analysis
Figure 24 Major Players Adopted the Inorganic Growth Strategy of Agreements, Collaborations, & Partnerships Between 2011 & 2014
Figure 25 Supply Chain Analysis
Figure 26 Mycoplasma Testing Market, By Product
Figure 27 KITS & Reagents Commanded the Largest Share of Mycoplasma Testing Market in 2014
Figure 28 Mycoplasma Testing KITS & Reagents Market, By Type
Figure 29 PCR Assays Commanded the Largest Share of KITS & Reagents in 2014
Figure 30 Asia to Be the Fastest Growing Segment of the KITS & Reagents Market in the Frocast Period
Figure 31 North America Commanded the Largest Share of PCR Assays Segment in 2014
Figure 32 Asia to Be the Fastest Growing Segment of Nucleic Acid Detection KITS Market in the Forecast Period
Figure 33 Asia to Be the Fastest Growing Segment of the Stains Market in the Forecast Period
Figure 34 North America Commanded the Largest Share of Standards & Controls Segment in 2014
Figure 35 Asia to Be the Fastest Growing Segment of the of Other KITS & Reagents Market in the Forecast Period
Figure 36 North America Commanded the Largest Share of Instruments Segment in 2014
Figure 37 Asia to Be the Fastest Growing Segment of the Services Market in the Forecast Period
Figure 38 Global Mycoplasma Testing Market, By Technology
Figure 39 PCR Will Be the Largest Application Segment in Global Mycoplasma Testing Market
Figure 40 North America Dominated the Largest Share of the PCR Technology Segment in 2014
Figure 41 North America Dominated the Largest Share of the Elisa Technology Segment in 2014
Figure 42 North America Dominated the Largest Share of the Direct Assay Technology Segment in 2014
Figure 43 North America Dominated the Largest Share of the Indirect Assay Technology Segment in 2014
Figure 44 North America Dominated the Largest Share of the Microbial Culture Techniques Technology Segment in 2014
Figure 45 North America Dominated the Largest Share of the Enzymatic Methods Technology Segment in 2014
Figure 46 Mycoplasma Testing Market Segmentation, By Application
Figure 47 Cell Line Testing Will Be the Fastest-Growing Application Segment
Figure 48 North America Commanded the Largest Share of the Cell Line Testing Segment in 2014
Figure 49 North America Dominated the Virus Testing Segment in 2014
Figure 50 Asian Market for the End of Production Cells Testing Market to Grow at the Highest CAGR
Figure 51 North America Held the Largest Share of the Other Applications Segment in 2014
Figure 52 Mycoplasma Testing Market Segmentation, By End User
Figure 53 Market Size, By End User, 2014 vs. 2019 ($Million)
Figure 54 Large Number of Granted Patents Enhancing Growth of the Pharmaceutical & Biotechnology Companies Segment
Figure 55 North America Commanded the Largest Share of the Pharmaceutical and Biotechnology Companies Segment in 2014
Figure 56 North America Commanded the Largest Share of the Contract Research Organizations End-User Segment in 2014
Figure 57 Public Sector Research Funding is Driving the Growth of the Academic Research Institutes Segment
Figure 58 Asian Mycoplasma Testing Market for Academic Research Institutes to Grow at Highest Rate in the Forecast Period
Figure 59 North America Commanded the Largest Share of the Cell Banks Segment in 2014
Figure 60 Asian Mycoplasma Testing Market for Other End Users to Grow at Highest Rate in the Forecast Period
Figure 61 Geographic Snapshot (2014)
Figure 62 Mycoplasma Testing Market, By Region CAGR 2014, Asia to Grow at the Highest Rate During the Forecast Period
Figure 63 North America: Mycoplasma Testing Market Size, By Country CAGR 2014, U.S. to Grow at A Faster Rate in the Forecast Period
Figure 64 North America: Market Snapshot(2014-2019): Availability of Life Science Research Funding is Driving the Market Growth
Figure 65 KITS & Reagents are Estimated to Be the Largest Product Segment in North America Mycoplasma Testing Market in 2014
Figure 66 North America: PCR Assays to Grow at the Highest CAGR From 2014 to 2019
Figure 67 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in North America
Figure 68 North America: Mycoplasma Testing Market Size, By Application (Market Size), 2014 vs. 2019
Figure 69 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in North America
Figure 70 KITS & Reagents are Estimated to Be the Largest Product Segment in U.S. in 2014
Figure 71 U.S.: PCR Assays to Grow at the Highest CAGR From 2014 to 2019
Figure 72 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in U.S.
Figure 73 U.S.: Mycoplasma Testing Market Size, By Application (Market Size), 2014 vs. 2019
Figure 74 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in U.S.
Figure 75 KITS & Reagents are Estimated to Be the Largest Product Segment in Canada in 2014
Figure 76 Canada: PCR Assays to Grow at the Highest CAGR From 2014 to 2019
Figure 77 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in Canada
Figure 78 Canada: Mycoplasma Testing Market Size, By Application (Market Size), 2014 vs. 2019
Figure 79 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in Canada
Figure 80 KITS & Reagents are Estimated to Be the Largest Product Segment in Europe in 2014
Figure 81 PCR Assays are Estimated to Be the Largest Segment in KITS & Reagents Market in Europe in 2014
Figure 82 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in Europe
Figure 83 Europe: Mycoplasma Testing Market Size, By Application (Market Size and Growth Rate), 2014 vs. 2019
Figure 84 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in Europe
Figure 85 KITS & Reagents are Estimated to Be the Largest Product Segment in Asia in 2014
Figure 86 Asia: PCR Assays to Grow at the Highest CAGR From 2014 to 2019
Figure 87 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in Asia
Figure 88 Asia: Market Size, By Application (Market Size and Growth Rate), 2014 vs. 2019
Figure 89 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in Asia
Figure 90 KITS & Reagents are Estimated to Be the Largest Product Segment in RoW in 2014
Figure 91 RoW: PCR Assays to Grow at the Highest CAGR From 2014 to 2019
Figure 92 PCR Will Be the Largest Technology Segment in Mycoplasma Testing Market in RoW
Figure 93 RoW: Market Size, By Application (Market Size), 2014 vs. 2019
Figure 94 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the Mycoplasma Testing End-Users Market in RoW
Figure 95 Agreements, Collaborations, and Partnerships are Key Strategies Adopted By Players in this Market
Figure 96 Global Mycoplasma Testing Market Share Analysis, By Key Players, 2014
Figure 97 Competitive Situation and Trends: Agreements, Collaborations & Partnerships are the Key Growth Strategies
Figure 98 Financial Performances of the Leading Market Players
Figure 99 Company Snapshot: Charles River Laboratories International, Inc.
Figure 100 Company Snapshot: Lonza Group Ltd.
Figure 101 Company Snapshot: Merck KGaA (Germany).
Figure 102 Company Snapshot: Sigma-Aldrich Corporation
Figure 103 Company Snapshot: Thermo Fisher Scientific, Inc.

The global mycoplasma testing market is expected to reach $613.49 Million by 2019 from $340.29 Million in 2014, growing at a CAGR of 12.51% between 2014 and 2019. Mycoplasma testing market refers to a wide range of assays and services aimed at ensuring the quality and purity of products and raw materials used in the production of biologics for the pharmaceutical and biotech industries. Spending on R&D in life science research and growing biotechnology & pharmaceutical companies for life science research will drive the growth of this market.

This report segments the global mycoplasma testing market by products, technology, applications and end users. The global market product segments included in the report comprises of instruments, kits & reagents and services. The kits & reagents segment is further divided on the basis of type into stains, elimination kits, PCR assays, nucleic acid detection kits, standards & controls and other kits & reagents.

The technology segments included in the report includes microbial culture techniques, DNA staining, PCR, ELISA, direct assay, indirect assay and enzymatic methods. The applications included in this report are cell line testing, virus testing, end of production cells testing and other applications. The cell line testing applications had the largest share of the mycoplasma testing market in 2014. The cell line testing applications are expected to one of the fastest growing applications between 2014 and 2019.

On the basis of end users the global market report is segmented into biotechnology and pharmaceutical companies, academic research institutes, cell banks, contract research organizations and other end users.

The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global mycoplasma testing market in 2014. Asia regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increase in biopharmaceutical companies and spending on R&D in life science research from this region.

The major players in mycoplasma testing market include Merck KGaA (Germany), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), Lonza Group Ltd. (Switzerland), Charles River Laboratories International, Inc. (U.S.), Promo Cell GmbH (Germany), Bionique Testing Laboratories, Inc. (U.S.), American Type Culture Collection (U.S.), InvivoGen.(U.S.), Biological Industries Israel Beit Haemek Ltd. (Israel) and others.

Mycoplasma Testing Market

Source: MarketsandMarkets Analysis

Mycoplasma Testing Market

Source: MarketsandMarkets Analysis

Mycoplasma Testing Market

Source: MarketsandMarkets Analysis

Mycoplasma Testing Market

Source: MarketsandMarkets Analysis

Mycoplasma Testing Market

Source: MarketsandMarkets Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo